Clinical Research Directory
Browse clinical research sites, groups, and studies.
Ryme Medical TLD Pilot Study
Sponsor: Ryme Medical, Inc.
Summary
Targeted lung denervation (TLD) with the Ryme Medical Lung Denervation System in patients with chronic obstructive pulmonary disease (COPD) - Ryme Medical TLD Pilot Study
Official title: Targeted Lung Denervation (TLD) With the Ryme Medical Lung Denervation System in Patients With Chronic Obstructive Pulmonary Disease (COPD) - Ryme Medical TLD Pilot Study
Key Details
Gender
All
Age Range
40 Years - Any
Study Type
INTERVENTIONAL
Enrollment
60
Start Date
2024-03-06
Completion Date
2026-05
Last Updated
2025-08-13
Healthy Volunteers
No
Conditions
Interventions
Targeted Lung Denervation
Targeted Lung Denervation (TLD) is a bronchoscopically guided, minimally invasive procedure using the Ryme Medical Lung Denervation System
Locations (7)
Melbourne Health - The Royal Melbourne Hospital
Melbourne, Australia
Macquarie University
Sydney, Australia
Karl Landsteiner Institute for Lung Research
Vienna, Austria
Rigshospitalet
Copenhagen, Denmark
Healthycore
Tbilisi, Georgia
University of Groningen Medical Center
Groningen, Netherlands
Royal Brompton
London, United Kingdom